NCT07320820Not yet recruiting
Quality of Life and Functional Outcomes in Laryngeal Cancer Patients
Assessment of Quality of Life, Patient Satisfaction, Swallowing Function, Voice Outcomes, Pain, and Anxiety-Depression at Baseline and at 3-, 6-, and 12-Month Follow-Up in Patients Diagnosed With Laryngeal Squamous Cell Carcinoma: A Prospective Questionnaire-Based Study
Source: ClinicalTrials.gov · Last updated 22 Apr 2026
Brief summary (registry, in English)
Laryngeal squamous cell carcinomas are head and neck malignancies that directly affect both swallowing and voice functions and are associated with a significant deterioration in patients' quality of life throughout the treatment process. The aim of this study is to evaluate quality of life, voice and swallowing functions, pain, anxiety-depression levels, and patient satisfaction at the pre-treatment period and at the 3rd, 6th, and 12th months post-treatment in patients with laryngeal malignancies, using validated questionnaires, in order to: Elucidate the course of functional recovery following treatment, Individualize rehabilitation and follow-up strategies, and Examine the relationship between functional outcomes and oncological survival.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 13 Dec 2025
- Start date
- 2 Apr 2026
- Primary completion date
- 2 Jan 2027
- Lead sponsor
- Saglik Bilimleri Universitesi
- Diseases
- Head and neck cancer
- NCT number
- NCT07320820
What you commit to
- Study type: Observational
- Planned participants: 120
- From 2 Apr 2026 to the primary completion date, 2 Jan 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of comorbid conditions that may independently affect swallowing or voice functions.
- History of psychiatric disorders or use of psychiatric medications that may interfere with study participation or completion of patient-reported outcome measures.
Age
- Age \< 18 years.
Other
- Patients who withdraw consent or request to discontinue participation during or after the treatment period.
Who the study is looking for
- Age ≥ 18 years at the time of enrollment.
- Histopathologically confirmed diagnosis of laryngeal squamous cell carcinoma.
- Planned to undergo surgical treatment or radiotherapy/chemoradiotherapy as part of standard oncological care.
- Willing and able to participate in the study and to provide written informed consent.
- No history of psychiatric or neurological disorders that could impair comprehension, questionnaire completion, or study participation.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.